Chanda Sanjay

CIK 00015718202 companiesMENLO PARK, CA

SEC Profile

Transactions

Companies

Filings

CIK

0001571820

Recent Transactions

35 trades

Sale
AN2 Therapeutics, Inc.$ANTX
Common Stock
2026-01-06$1.01/sh−5,956→ 75,823 total
Sale
AN2 Therapeutics, Inc.$ANTX
Common Stock
2026-01-05$1.00/sh−3,295→ 81,779 total
Award
AN2 Therapeutics, Inc.$ANTX
Stock Option (right to buy)
2025-02-26+100,500→ 100,500 total
Award
AN2 Therapeutics, Inc.$ANTX
Common Stock
2025-02-26+50,250→ 80,074 total
Sale
AN2 Therapeutics, Inc.$ANTX
Common Stock
2025-01-03$1.34/sh−2,957→ 29,824 total
Award
AN2 Therapeutics, Inc.$ANTX
Common Stock
2024-03-15+27,500→ 28,235 total
Award
AN2 Therapeutics, Inc.$ANTX
Stock Option (right to buy)
2024-03-15+55,000→ 55,000 total
Award
AN2 Therapeutics, Inc.$ANTX
Common Stock
2024-03-15+27,500→ 28,235 total
Award
AN2 Therapeutics, Inc.$ANTX
Stock Option (right to buy)
2023-02-15+57,950→ 57,950 total
Award
AN2 Therapeutics, Inc.$ANTX
Stock Option (right to buy)
2022-05-12+66,000→ 66,000 total
Exercise/Conversion
Anacor Pharmaceuticals, Inc.
Common Stock
2015-03-04$7.55/sh+48→ 29,135 total
Sale
Anacor Pharmaceuticals, Inc.
Common Stock
2015-03-04$45.00/sh−48→ 29,087 total
Exercise/Conversion
Anacor Pharmaceuticals, Inc.
Stock Option (right to buy)
2015-03-04$7.25/sh−4,952→ 0 total
Exercise/Conversion
Anacor Pharmaceuticals, Inc.
Stock Option (right to buy)
2015-03-04$7.55/sh−48→ 13,552 total
Exercise/Conversion
Anacor Pharmaceuticals, Inc.
Common Stock
2015-03-04$7.25/sh+4,952→ 34,039 total
Sale
Anacor Pharmaceuticals, Inc.
Common Stock
2015-03-04$45.00/sh−4,952→ 29,087 total
Award
Anacor Pharmaceuticals, Inc.
Performance Restricted Stock Units
2015-02-03+1,475→ 1,475 total
Award
Anacor Pharmaceuticals, Inc.
Stock Option (right to buy)
2015-02-03+20,845→ 20,845 total
Award
Anacor Pharmaceuticals, Inc.
Common Stock
2015-02-03+5,020→ 29,087 total
Exercise/Conversion
Anacor Pharmaceuticals, Inc.
Common Stock
2014-12-19$6.92/sh+7,011→ 11,006 total
Exercise/Conversion
Anacor Pharmaceuticals, Inc.
Stock Option (right to buy)
2014-12-19$5.59/sh−12,062→ 14,938 total
Exercise/Conversion
Anacor Pharmaceuticals, Inc.
Common Stock
2014-12-19$5.59/sh+12,062→ 23,068 total
Exercise/Conversion
Anacor Pharmaceuticals, Inc.
Stock Option (right to buy)
2014-12-19$6.92/sh−7,011→ 18,489 total
Exercise/Conversion
Anacor Pharmaceuticals, Inc.
Common Stock
2014-11-26$7.25/sh+5,000→ 8,995 total
Sale
Anacor Pharmaceuticals, Inc.
Common Stock
2014-11-26$35.00/sh−5,000→ 3,995 total
Exercise/Conversion
Anacor Pharmaceuticals, Inc.
Stock Option (right to buy)
2014-11-26$7.25/sh−5,000→ 4,952 total
Exercise/Conversion
Anacor Pharmaceuticals, Inc.
Stock Option (right to buy)
2014-09-10$5.00/sh−4,953→ 0 total
Exercise/Conversion
Anacor Pharmaceuticals, Inc.
Common Stock
2014-09-10$5.00/sh+4,953→ 8,948 total
Sale
Anacor Pharmaceuticals, Inc.
Common Stock
2014-09-10$24.25/sh−5,047→ 3,995 total
Exercise/Conversion
Anacor Pharmaceuticals, Inc.
Common Stock
2014-09-10$7.25/sh+5,047→ 9,042 total
Sale
Anacor Pharmaceuticals, Inc.
Common Stock
2014-09-10$24.25/sh−4,953→ 3,995 total
Exercise/Conversion
Anacor Pharmaceuticals, Inc.
Stock Option (right to buy)
2014-09-10$7.25/sh−5,047→ 9,952 total
Award
Anacor Pharmaceuticals, Inc.
Stock Option (right to buy)
2014-02-07+47,000→ 47,000 total
Award
Anacor Pharmaceuticals, Inc.
Stock Option (right to buy)
2013-11-07+30,000→ 30,000 total
Award
Anacor Pharmaceuticals, Inc.
Stock Option (right to buy)
2013-04-12+60,000→ 60,000 total

Companies

Recent Filings

Address

C/O AN2 THERAPEUTICS, INC. 1300 EL CAMINO REAL, SUITE 100

MENLO PARK, CA, 94027

View on SEC.gov